Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-003737

Senior VP - Drug Discovery gave up 9,387 shares (to pay taxes)

  • Senior VP - Drug Discovery acquired 31,874 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-31 Exercise or conversion : show line 1 in the form +19,686 $1.20 $23,623 127,786 D
2019-01-31 Shares withheld for taxes : show line 2 in the form −7,702 $8.68 $66,853 120,084 D
2019-01-31 Exercise or conversion : show line 3 in the form +12,188 $1.20 $14,626 132,272 D
2019-01-31 Shares withheld for taxes : show line 4 in the form −1,685 $8.68 $14,626 130,587 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-31 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option −19,686 0 D
2019-01-31 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −12,188 0 D
Loading xslF345X03/form4.xml…